N-[(2H-1,3-benzodioxol-5-yl)methyl]-N~2~-methyl-N~2~-(2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepine-7-sulfonyl)glycinamide
Chemical Structure Depiction of
N-[(2H-1,3-benzodioxol-5-yl)methyl]-N~2~-methyl-N~2~-(2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepine-7-sulfonyl)glycinamide
N-[(2H-1,3-benzodioxol-5-yl)methyl]-N~2~-methyl-N~2~-(2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepine-7-sulfonyl)glycinamide
Compound characteristics
| Compound ID: | E977-0281 |
| Compound Name: | N-[(2H-1,3-benzodioxol-5-yl)methyl]-N~2~-methyl-N~2~-(2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepine-7-sulfonyl)glycinamide |
| Molecular Weight: | 445.49 |
| Molecular Formula: | C21 H23 N3 O6 S |
| Smiles: | CN(CC(NCc1ccc2c(c1)OCO2)=O)S(c1ccc2c(CCCC(N2)=O)c1)(=O)=O |
| Stereo: | ACHIRAL |
| logP: | 1.5126 |
| logD: | 1.5126 |
| logSw: | -2.6201 |
| Hydrogen bond acceptors count: | 11 |
| Hydrogen bond donors count: | 2 |
| Polar surface area: | 99.541 |
| InChI Key: | FNWBYBUILVTYLO-UHFFFAOYSA-N |